Presurgery 72‐h fasting in GB patients leads to adaptations of plasma lipids and polar metabolites. Fasting reduces lysophosphatidylcholines and increases free fatty acids, shifts triglycerides toward long‐chain TGs and increases branched‐chain amino acids, alpha aminobutyric acid, and uric acid.
Iris Divé+7 more
wiley +1 more source
Cross-kingdom regulation of gene expression in giant pandas via plant-derived miRNA. [PDF]
Tan H+9 more
europepmc +1 more source
Role of long-chain polyunsaturated fatty acids, eicosapentaenoic and docosahexaenoic, in the regulation of gene expression during the development of obesity: a systematic review. [PDF]
Sandoval C+5 more
europepmc +1 more source
Dual regulation of the expression of the polyubiquitin gene by cyclic AMP and heat shock in yeast. [PDF]
Kan Tanaka+2 more
openalex +1 more source
Transcriptome‐wide analysis of circRNA and RBP profiles and their molecular relevance for GBM
CircRNAs are differentially expressed in glioblastoma primary tumors and might serve as therapeutic targets and diagnostic markers. The investigation of circRNA and RNA‐binding proteins (RBPs) interactions shows that distinct RBPs play a role in circRNA biogenesis and function.
Julia Latowska‐Łysiak+14 more
wiley +1 more source
Temporal regulation of gene expression through integration of p53 dynamics and modifications. [PDF]
Lu D+9 more
europepmc +1 more source
FACT regulates pluripotency through proximal and distal regulation of gene expression in murine embryonic stem cells. [PDF]
Klein DC+3 more
europepmc +1 more source
RNA polymerase involvement in the regulation of expression of Salmonella typhimurium pyr genes. Isolation and characterization of a fluorouracil-resistant mutant with high, constitutive expression of the pyrB and pyrE genes due to a mutation in rpoBC. [PDF]
K.F. Jensen, Jan Neuhard, Lise Schack
openalex +1 more source
This study investigates an alternative approach to reactivating the oncosuppressor p53 in cancer. A short peptide targeting the association of the two p53 inhibitors, MDM2 and MDM4, induces an otherwise therapeutically active p53 with unique features that promote cell death and potentially reduce toxicity towards proliferating nontumor cells.
Sonia Valentini+10 more
wiley +1 more source